GROOVE BOTANICALS INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that GROOVE BOTANICALS INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($130.8K) | Aug 25, 2025 |
| FY2025 | Mar 31, 2024 | ($202.1K) | Aug 25, 2025 |
| FY2024 | Mar 31, 2023 | ($120.7K) | Aug 15, 2024 |
| FY2017 | Mar 31, 2017 | ($243.2K) | Jan 11, 2019 |
| FY2017 | Mar 31, 2016 | ($2.50M) | Jan 11, 2019 |
| FY2016 | Mar 31, 2015 | $100.3K | Aug 28, 2018 |
| FY2014 | Mar 31, 2014 | ($786.0K) | Aug 14, 2015 |
| FY2013 | Mar 31, 2013 | ($749.3K) | Sep 30, 2014 |
| FY2012 | Mar 31, 2012 | ($737.2K) | Aug 20, 2013 |
| FY2011 | Mar 31, 2011 | ($1.32M) | Jul 13, 2012 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($130.8K) | Aug 25, 2025 |
| FY2025 | Mar 31, 2024 | ($266.6K) | Aug 25, 2025 |
| FY2024 | Mar 31, 2023 | ($175.5K) | Aug 15, 2024 |
| FY2017 | Mar 31, 2017 | ($237.2K) | Jan 11, 2019 |
| FY2017 | Mar 31, 2016 | ($2.77M) | Jan 11, 2019 |
| FY2016 | Mar 31, 2015 | ($374.1K) | Aug 28, 2018 |
| FY2014 | Mar 31, 2014 | ($643.1K) | Aug 14, 2015 |
| FY2013 | Mar 31, 2013 | ($574.5K) | Sep 30, 2014 |
| FY2012 | Mar 31, 2012 | ($483.8K) | Aug 20, 2013 |
| FY2011 | Mar 31, 2011 | ($1.19M) | Jul 13, 2012 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $73.1K | Aug 25, 2025 |
| FY2025 | Mar 31, 2024 | $73.7K | Aug 25, 2025 |
| FY2024 | Mar 31, 2023 | $75.5K | Aug 15, 2024 |
| FY2017 | Mar 31, 2017 | $183.8K | Jan 11, 2019 |
| FY2017 | Mar 31, 2016 | $788.8K | Jan 11, 2019 |
| FY2016 | Mar 31, 2015 | $285.5K | Aug 28, 2018 |
| FY2014 | Mar 31, 2014 | $602.3K | Aug 14, 2015 |
| FY2013 | Mar 31, 2013 | $537.0K | Sep 30, 2014 |
| FY2012 | Mar 31, 2012 | $538.8K | Aug 20, 2013 |
| FY2011 | Mar 31, 2011 | $887.4K | Jul 13, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($107.4K) | Aug 25, 2025 |
| FY2025 | Mar 31, 2024 | ($86.8K) | Aug 25, 2025 |
| FY2024 | Mar 31, 2023 | ($95.5K) | Aug 15, 2024 |
| FY2017 | Mar 31, 2017 | ($103.6K) | Jan 11, 2019 |
| FY2017 | Mar 31, 2016 | ($348.9K) | Jan 11, 2019 |
| FY2016 | Mar 31, 2015 | ($230.3K) | Aug 28, 2018 |
| FY2014 | Mar 31, 2014 | ($381.6K) | Aug 14, 2015 |
| FY2013 | Mar 31, 2013 | ($333.9K) | Sep 30, 2014 |
| FY2012 | Mar 31, 2012 | ($430.3K) | Aug 20, 2013 |
| FY2011 | Mar 31, 2011 | ($701.3K) | Jul 13, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $4.5K | Aug 25, 2025 |
| FY2025 | Mar 31, 2024 | $2.1K | Aug 25, 2025 |
| FY2024 | Mar 31, 2023 | $5.0K | Aug 15, 2024 |
| FY2017 | Mar 31, 2017 | $325.2K | Jan 11, 2019 |
| FY2017 | Mar 31, 2016 | $373.6K | Jan 11, 2019 |
| FY2016 | Mar 31, 2015 | $2.75M | Aug 28, 2018 |
| FY2014 | Mar 31, 2014 | $2.73M | Aug 14, 2015 |
| FY2013 | Mar 31, 2013 | $2.57M | Sep 30, 2014 |
| FY2012 | Mar 31, 2012 | $2.62M | Aug 20, 2013 |
| FY2011 | Mar 31, 2011 | $2.70M | Jul 13, 2012 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.11M | Aug 25, 2025 |
| FY2025 | Mar 31, 2024 | $762.7K | Aug 25, 2025 |
| FY2024 | Mar 31, 2023 | $443.3K | Aug 15, 2024 |
| FY2017 | Mar 31, 2017 | $1.19M | Jan 11, 2019 |
| FY2017 | Mar 31, 2016 | $921.4K | Jan 11, 2019 |
| FY2016 | Mar 31, 2015 | $1.06M | Aug 28, 2018 |
| FY2014 | Mar 31, 2014 | $1.52M | Aug 14, 2015 |
| FY2013 | Mar 31, 2013 | $2.12M | Sep 30, 2014 |
| FY2012 | Mar 31, 2012 | $2.03M | Aug 20, 2013 |
| FY2011 | Mar 31, 2011 | $1.65M | Jul 13, 2012 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($1.11M) | Aug 25, 2025 |
| FY2025 | Mar 31, 2024 | ($760.6K) | Aug 25, 2025 |
| FY2025 | Mar 31, 2023 | ($438.3K) | Aug 25, 2025 |
| FY2024 | Mar 31, 2022 | ($454.9K) | Aug 15, 2024 |
| FY2017 | Mar 31, 2017 | ($1.00M) | Jan 11, 2019 |
| FY2017 | Mar 31, 2016 | ($598.5K) | Jan 11, 2019 |
| FY2016 | Mar 31, 2015 | $1.69M | Aug 28, 2018 |
| FY2014 | Mar 31, 2014 | $1.21M | Aug 14, 2015 |
| FY2014 | Mar 31, 2013 | $442.1K | Aug 14, 2015 |
| FY2013 | Mar 31, 2012 | $738.0K | Sep 30, 2014 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($35.20M) | Aug 25, 2025 |
| FY2025 | Mar 31, 2024 | ($34.85M) | Aug 25, 2025 |
| FY2024 | Mar 31, 2023 | ($34.43M) | Aug 15, 2024 |
| FY2017 | Mar 31, 2017 | ($34.01M) | Jan 11, 2019 |
| FY2017 | Mar 31, 2016 | ($33.61M) | Jan 11, 2019 |
| FY2016 | Mar 31, 2015 | ($30.90M) | Aug 28, 2018 |
| FY2014 | Mar 31, 2014 | ($30.82M) | Aug 14, 2015 |
| FY2013 | Mar 31, 2013 | ($29.97M) | Sep 30, 2014 |
| FY2012 | Mar 31, 2012 | ($29.22M) | Aug 20, 2013 |
| FY2011 | Mar 31, 2011 | ($28.49M) | Jul 13, 2012 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $2.0K | Aug 25, 2025 |
| FY2025 | Mar 31, 2024 | $1.7K | Aug 25, 2025 |
| FY2024 | Mar 31, 2023 | $4.6K | Aug 15, 2024 |
| FY2017 | Mar 31, 2017 | $104.6K | Jan 11, 2019 |
| FY2017 | Mar 31, 2016 | $108.2K | Jan 11, 2019 |
| FY2017 | Mar 31, 2015 | $135.7K | Jan 11, 2019 |
| FY2016 | Mar 31, 2014 | $223.9K | Aug 28, 2018 |
| FY2014 | Mar 31, 2013 | $129.9K | Aug 14, 2015 |
| FY2013 | Mar 31, 2012 | $114.5K | Sep 30, 2014 |
| FY2012 | Mar 31, 2011 | $311.8K | Aug 20, 2013 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Mar 31, 2016 | $149.2K | Aug 28, 2018 |
| FY2014 | Mar 31, 2015 | $224.3K | Aug 14, 2015 |
| FY2013 | Mar 31, 2014 | $514.3K | Sep 30, 2014 |
| FY2012 | Mar 31, 2013 | $1.11M | Aug 20, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Aug 25, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Aug 25, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Aug 15, 2024 |
| FY2016 | Mar 31, 2016 | 0 | Aug 28, 2018 |
| FY2016 | Mar 31, 2015 | 0 | Aug 28, 2018 |
| FY2014 | Mar 31, 2014 | 0 | Aug 14, 2015 |
| FY2013 | Mar 31, 2013 | 0 | Sep 30, 2014 |
| FY2012 | Mar 31, 2012 | 0 | Aug 20, 2013 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Aug 25, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Aug 25, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Aug 15, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 59.64M | Aug 25, 2025 |
| FY2025 | Mar 31, 2024 | 59.64M | Aug 25, 2025 |
| FY2024 | Mar 31, 2023 | 57.64M | Aug 15, 2024 |
| FY2017 | Mar 31, 2017 | 18.20M | Jan 11, 2019 |
| FY2017 | Mar 31, 2016 | 18.20M | Jan 11, 2019 |
| FY2016 | Mar 31, 2015 | 16.55M | Aug 28, 2018 |
| FY2014 | Mar 31, 2014 | 11.66M | Aug 14, 2015 |
| FY2013 | Mar 31, 2013 | 6.21M | Sep 30, 2014 |
| FY2012 | Mar 31, 2012 | 2.56M | Aug 20, 2013 |
| FY2011 | Mar 31, 2011 | 479.56M | Jul 13, 2012 |